Nutritional abnormalities in chronic obstructive pulmonary disease;Alteraciones nutricionales en la enfermedad pulmonar obstructiva crónica

Medicina Clinica

Volumn 143, Issue 2, 2014, Pages 78-84

  Gea, Joaquim ^a   Martínez Llorens, Juana ^a   Barreiro, Esther ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Anabolic drugs; Chronic obstruction pulmonary disease; Exercise; Lean mass; Low weight; Muscle dysfunction; Nutrition

Indexed keywords

ANABOLIC AGENT; DEUTERIUM;

AGING; ANTHROPOMETRY; BIOENERGY; BODY MASS; CALORIC INTAKE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DILUTION; DISEASE ASSOCIATION; ENERGY; EXERCISE; GEOGRAPHY; HYPOXEMIA; IMPEDANCE; INFLAMMATION; LEAN BODY WEIGHT; LIFESTYLE; MALNUTRITION; MUSCLE DISEASE; NUTRITIONAL DISORDER; NUTRITIONAL SUPPORT; PHYSICAL ACTIVITY; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SMOKING; STUDY DESIGN; COMPLICATION; HUMAN; METABOLISM; NUTRITIONAL STATUS; RISK FACTOR;

HUMANS; MALNUTRITION; NUTRITIONAL STATUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84903531510     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.05.040     Document Type: Review

References (60)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [consultado May 2013]. Disponible en: http://www.goldcopd.org/
2. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur Respir J 33 2009 1165 1185
3. J. Gea, A. Agusti, and J. Roca Pathophysiology of muscle dysfunction in COPD J Appl Physiol 114 2013 1222 1234
4. E.S. Wan, M.H. Cho, N. Boutaoui, B.J. Klanderman, J.S. Sylvia, J.P. Ziniti Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate End-Points (ECLIPSE); Norway-Bergen cohort; National Emphysema Treatment Trial; COPD Gene investigators Genome-wide association analysis of body mass in chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 45 2011 304 310
5. M.A. Vermeeren, E.C. Creutzberg, A.M. Schols, D.S. Postma, W.R. Pieters, and A.C. Roldaan et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD Respir Med 100 2006 1349 1355
6. E. Balcells, J.M. Antó, J. Gea, F.P. Gómez, E. Rodríguez, and A. Marin et al. Characteristics of patients admitted for the first time for COPD exacerbation Respir Med 103 2009 1293 1302
7. A.M. Schols, J. Slangen, L. Volovics, and E.F. Wouters Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791 1797
8. E.B. Swallow, D. Reyes, N.S. Hopkinson, W.D. Man, R. Porcher, and E.J. Cetti et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease Thorax 62 2007 115 120
9. A. Agustí, L.D. Edwards, S.I. Rennard, W. MacNee, R. Tal-Singer, and B.E. Miller et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype PLoS One 7 2012 e37483
10. M. Miravitlles, J. Soler-Cataluña, M. Calle, J. Molina, P. Almagro, J.A. Quintano Spanish Society of Pulmonology and Thoracic Surgery Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery Arch Bronconeumol 48 2012 247 257
11. J. Garcia-Aymerich, F.P. Gómez, M. Benet, E. Farrero, X. Basagaña, and À. Gayete et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes Thorax 66 2011 430 437
12. B.R. Celli, C.G. Cote, J.M. Marin, C. Casanova, M. Montes de Oca, and R.A. Mendez et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
13. L.K. Mahan, and S. Escott-Stump Krause's food, nutrition & diet therapy 10th ed 2000 W.B. Saunders Co Philadelphia (Pa) 970 986
14. World Health Organization (WHO). BMI classification [consultado May 2013]. Disponible en: apps.who.int/bmi/index.jsp?introPage=intro-3.html
15. A. Coin, G. Sergi, N. Minicuci, S. Giannini, E. Barbiero, and E. Manzato et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population Clin Nutr 27 2008 87 94
16. A.M. Schols, E.F. Wouters, P.B. Soeters, and K.R. Westerterp Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease Am J Clin Nutr 53 1991 421 424
17. A. Gurgun, S. Deniz, M. Argin, and H. Karapolat Effects of nutritional supplementation combined with conventional pulmonary rehabilitation in muscle-wasted chronic obstructive pulmonary disease: A prospective, randomized and controlled study Respirology 18 2013 495 500
18. A.M. Petersen, F. Magkos, P. Atherton, A. Selby, K. Smith, and M.J. Rennie et al. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle Am J Physiol Endocrinol Metab 293 2007 E843 E848
19. E. Barreiro, V.I. Peinado, J.B. Galdiz, E. Ferrer, J. Marin-Corral, and F. Sánchez et al. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction Am J Respir Crit Care Med 182 2010 477 488
20. P. Laveneziana, P. Palange ERS Research Seminar Faculty Physical activity, nutritional status and systemic inflammation in COPD Eur Respir J 40 2012 522 529
21. D.A. Rodriguez, S. Kalko, E. Puig-Vilanova, M. Perez-Olabarría, F. Falciani, and J. Gea et al. Muscle and blood redox status after exercise training in severe COPD patients Free Radic Biol Med 52 2012 88 94
22. E. Barreiro, D. Ferrer, F. Sanchez, J. Minguella, J. Marin-Corral, and J. Martinez-Llorens et al. Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD J Appl Physiol 111 2011 808 817
23. G. Gayan-Ramirez, and M. Decramer Mechanisms of striated muscle dysfunction during acute exacerbations of COPD J Appl Physiol 114 2013 1291 1299
24. G. Sergi, A. Coin, S. Marin, A. Vianello, A. Manzan, and S. Peruzza et al. Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease Respir Med 100 2006 1918 1924
25. P. Borghetti, R. Saleri, E. Mocchegiani, A. Corradi, and P. Martelli Infection, immunity and the neuroendocrine response Vet Immunol Immunopathol 130 2009 141 162
26. I.S. Anand, Y. Chandrashekhar, R. Ferrari, R. Sarma, R. Guleria, and S.K. Jindal et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery Circulation 86 1992 12 21
27. E.C. Creutzberg, and R. Casaburi Endocrinological disturbances in chronic obstructive pulmonary disease Eur Respir J 22 Suppl 46 2003 76s 80s
28. F. Laghi, W.E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M.J. Tobin Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 598 605
29. S. Bhasin, G.R. Cunningham, F.J. Hayes, A.M. Matsumoto, P.J. Snyder, R.S. Swerdloff Task Force, Endocrine Society Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559
30. B. Van den Borst, H.R. Gosker, G. Wesseling, W. de Jager, V.A. Hellwig, and F.J. Snepvangers et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease Am J Clin Nutr 94 2011 1504 1512
31. F. Karadag, A.B. Karul, O. Cildag, M. Yilmaz, and H. Ozcan Biomarkers of systemic inflammation in stable and exacerbation phases of COPD Lung 186 2008 403 409
32. P.O. Hasselgren, N. Alamdari, Z. Aversa, P. Gonnella, I.J. Smith, and S. Tizio Corticosteroids and muscle wasting: Role of transcription factors, nuclear cofactors, and hyperacetylation Curr Opin Clin Nutr Metab Care 13 2010 423 428
33. C.A. Raguso, and C. Luthy Nutritional status in chronic obstructive pulmonary disease: Role of hypoxia Nutrition 27 2011 138 143
34. B.K. England, J.L. Chastain, and W.E. Mitch Abnormalities in protein synthesis and degradation induced by extracellular pH in BC3H1 myocytes Am J Physiol 260 1991 C277 C282
35. C. Yamamoto, T. Yoneda, M. Yoshikawa, A. Fu, I. Takenaka, and A. Kobayashi et al. The relationship between a decrease in fat mass and serum levels of TNF-alpha in patients with chronic obstructive pulmonary disease Nihon Kyobu Shikkan Gakkai Zasshi 35 1997 1191 1195
36. F.M. Franssen, H.P. Sauerwein, E.P. Rutten, E.F. Wouters, and A.M. Schols Whole-body resting and exercise-induced lipolysis in sarcopenic patients with COPD Eur Respir J 32 2008 1466 1471
37. R. Tkacova, J. Ukropec, P. Skyba, B. Ukropcova, P. Pobeha, and T. Kurdiova et al. Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease Respiration 81 2011 386 393
38. S. Kirdar, M. Serter, E. Ceylan, A.G. Sener, T. Kavak, and F. Karadaǧ Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease Scand J Clin Lab Invest 69 2009 219 224
39. D.R. Engineer, and J.M. Garcia Leptin in anorexia and cachexia syndrome Int J Pept 2012 2012 287457
40. A.A. Ionescu, and E. Schoon Osteoporosis in chronic obstructive pulmonary disease Eur Respir J Suppl 46 2003 64s 75s
41. W.L. Morrison, J.N. Gibson, C. Scrimgeour, and M.J. Rennie Muscle wasting in emphysema Clin Sci (Lond) 75 1988 415 420
42. C. Fermoselle, R. Rabinovich, P. Ausín, E. Puig-Vilanova, C. Coronell, and F. Sanchez et al. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J 40 2012 851 862
43. A.M. Schols, P.B. Soeters, R. Mostert, W.H. Saris, and E.F. Wouters Energy balance in chronic obstructive pulmonary disease Am Rev Respir Dis 143 1991 1248 1252
44. S.N. Hussain, and M. Sandri Role of autophagy in COPD skeletal muscle dysfunction J Appl Physiol 114 2012 1273 1281
45. J.F. Garvey, C.T. Taylor, and W.T. McNicholas Cardiovascular disease in obstructive sleep apnoea syndrome: The role of intermittent hypoxia and inflammation Eur Respir J 33 2009 1195 1205
46. C. Fermoselle, F. Sanchez, and E. Barreiro Reduction of muscle mass mediated by myostatin in an experimental model of pulmonary emphysema Arch Bronconeumol 47 2011 590 598
47. C.E. Weekes, P.W. Emery, and M. Elia Dietary counselling and food fortification in stable COPD: A randomised trial Thorax 64 2009 326 331
48. J. Efthimiou, J. Fleming, C. Gomes, and S.G. Spiro The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease Am Rev Respir Dis 137 1988 1075 1082
49. F. Maltais, M. Decramer, E. Barreiro, Y. Burelle, R. Casaburi, and R. Debigaré et al. An official American Thoracic Society and European Respiratory Society statement; Update on limb muscle dysfunction in COPD Am J Respir Crit Care Med 2013 En prensa 2013
50. S.S. Yeh, B. DeGuzman, T. Kramer M012 Study Group Reversal of COPD-associated weight loss using the anabolic agent oxandrolone Chest 122 2002 421 428
51. B. Make, C. Piquette, T. Kramer, A. Ries, and R. Casaburi Oxandrolone increases weight and muscle mass in underweight COPD patients Chest 122 2002 73S
52. A.M. Schols, P.B. Soeters, R. Mostert, R.J. Pluymers, and E.F. Wouters Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial Am J Respir Crit Care Med 152 1995 1268 1274
53. E.C. Creutzberg, E.F. Wouters, R. Mostert, R.J. Pluymers, and A.M. Schols A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial Chest 124 2003 1733 1742
54. J. Weisberg, J. Wanger, J. Olson, B. Streit, C. Fogarty, and T. Martin et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients Chest 121 2002 1070 1078
55. G.S. Pape, M. Friedman, L.E. Underwood, and D.R. Clemmons The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease Chest 99 1991 1495 1500
56. L. Burdet, B. de Muralt, Y. Schutz, C. Pichard, and J.W. Fitting Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study Am J Respir Crit Care Med 156 1997 1800 1806
57. Z.S. Xu, Z.Y. Bao, Z.Y. Wang, G.J. Yang, D.F. Zhu, and L. Zhang et al. The changes of ghrelin, growth hormone, growth hormone releasing hormone and their clinical significances in patients with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 51 2012 536 539
58. N. Nagaya, T. Itoh, S. Murakami, H. Oya, M. Uematsu, and K. Miyatake et al. Treatment of cachexia with ghrelin in patients with COPD Chest 128 2005 1187 1193
59. K. Miki, R. Maekura, N. Nagaya, M. Nakazato, H. Kimura, and S. Murakami et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: A multicenter, randomized, double-blind, placebo-controlled trial PLoS One 7 2012 e35708
60. F. Maltais, D.E. O'Donnell, A.M.W.J. Schols, P. Hernandez, J.M. Tellier, and B. Lussier et al. Effect of TH9507, a growth hormone releasing factor (GFR) analog, on functional performance in patients with COPD [Abstract] Eur Respir J 24 Suppl 48 2004 Abstract P1603